Ignite Creation Date:
2024-05-06 @ 3:25 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02283177
Status:
COMPLETED
Last Update Posted:
2024-02-02
First Post:
2014-10-29
Brief Title:
A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations
Sponsor:
Arog Pharmaceuticals Inc
Organization:
Arog Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2019-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-29
First Submit QC Date:
November 3 2014
Study First Post Date:
2014-11-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-02-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-09
Last Update Post Date:
2024-02-02
Last Update Post Date Type:
ACTUAL